S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 129.4 SEK 0.7%
Market Cap: 6.6B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Surgical Science Sweden AB
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Surgical Science Sweden AB
Total Current Liabilities Peer Comparison

Comparables:
EKTA B
CEVI
GETI B
ARJO B
S
STIL

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgical Science Sweden AB
STO:SUS
Total Current Liabilities
kr256.3m
CAGR 3-Years
61%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Total Current Liabilities
kr14B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Total Current Liabilities
kr127m
CAGR 3-Years
1%
CAGR 5-Years
11%
CAGR 10-Years
13%
Getinge AB
STO:GETI B
Total Current Liabilities
kr13.2B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Total Current Liabilities
kr4.4B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Total Current Liabilities
kr183.8m
CAGR 3-Years
84%
CAGR 5-Years
43%
CAGR 10-Years
28%

See Also

What is Surgical Science Sweden AB's Total Current Liabilities?
Total Current Liabilities
256.3m SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Total Current Liabilities amounts to 256.3m SEK.

What is Surgical Science Sweden AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
67%

Over the last year, the Total Current Liabilities growth was -26%. The average annual Total Current Liabilities growth rates for Surgical Science Sweden AB have been 61% over the past three years , 67% over the past five years .

Back to Top